🔴 Citius Pharmaceuticals is trading 5.1% down today amid routine volatility and a broader market decline

Citius Pharmaceuticals is trading 5.1% down today at $0.55 amid routine volatility and a broader market decline.

• The move follows a low-volume bounce last week that lacked follow-through, with no new company-specific developments, FDA decisions, or earnings reports.
• Today's price action appears to be routine volatility for the thinly traded micro-cap name, occurring against a broadly weaker U.S. equity market backdrop.